Status:
COMPLETED
Thromboprophylaxis by Low Molecular Heparin During the Post-partum Period
Lead Sponsor:
Centre Hospitalier Sud Francilien
Conditions:
Thromboembolic Disease
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this study is to determine the current level of adequacy of the thromboprophylaxis prescriptions with the specific institutional protocol during the post-partum period. The institutiona...
Detailed Description
Venous thromboembolism (VTE) became the 4th cause of maternal mortality and the 2nd direct cause of maternal mortality in France. The re are only few randomized studies on the thromboprophylaxis duri...
Eligibility Criteria
Inclusion
- \>18 ages
- Who had given birth at Centre Hospitalier Sud Francilien
- Hospitalized during the puerperium at Centre Hospitalier Sud Francilien
- Being informed of the clinical trial and had offered any opposition for data collection
Exclusion
- Curative treatment of thrombosis by Low molecular-weight or unfractioned heparin during pregnancy or post-partum period
- Curative anticoagulant therapy for any cause
Key Trial Info
Start Date :
October 8 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 9 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04883385
Start Date
October 8 2021
End Date
July 9 2022
Last Update
September 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, 91106